{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:40:03Z","timestamp":1748893203271,"version":"3.41.0"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,20]]},"DOI":"10.1097\/cm9.0000000000002870","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T13:07:17Z","timestamp":1696943237000},"page":"1249-1251","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic implications of overt congestion in heart failure with preserved ejection fraction and the interaction with spironolactone: Insights from TOPCAT"],"prefix":"10.1097","volume":"137","author":[{"given":"Yingwen","family":"Lin","sequence":"first","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengli","family":"Zhao","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Clinical Pharmacology, Medical Research Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510515, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongtu","family":"Hu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juncong","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingli","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingchun","family":"Zeng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,10,10]]},"reference":[{"key":"R1-20250602","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/ehv464","article-title":"Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction","volume":"37","author":"Solomon","year":"2016","journal-title":"Eur Heart J"},{"key":"R2-20250602","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ahj.2011.09.007","article-title":"Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction","volume":"162","author":"Desai","year":"2011","journal-title":"Am Heart J"},{"key":"R3-20250602","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006125","article-title":"Utility of the cardiovascular physical examination and impact of spironolactone in heart failure with preserved ejection fraction","volume":"12","author":"Selvaraj","year":"2019","journal-title":"Circ Heart Fail"},{"key":"R4-20250602","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ehjcvp\/pvw016","article-title":"Mineralocorticoid receptor antagonists in patients with heart failure: Current experience and future perspectives","volume":"3","author":"Pitt","year":"2017","journal-title":"Eur Heart J Cardiovasc Pharmacother"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:03:57Z","timestamp":1748891037000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":4,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002870","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"type":"print","value":"0366-6999"},{"type":"electronic","value":"2542-5641"}],"subject":[],"published":{"date-parts":[[2023,10,10]]},"assertion":[{"value":"2023-04-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}